Michael A. Kelly

Michael A. Kelly

DirectoratDMC Global· In proxies 2023–2025

Michael A. Kelly sits on 7 public boards.

Boards1

  • DMC GlobalDirector · 5 yr on the boardIndependentCompensation (Chair), Corporate Governance and Nominating, Risk—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. DMC GlobalPublic company · 3 yr
    • Director2023 – Present · 3 yrStock in role -58%
  2. Amicus Therapeutics, Inc.Public company
    • Director? – PresentNo stock prices for these years
  3. Mr. Kelly was appointed as a director in July 2020. He has more than two decades of executivePublic company
    • Director? – PresentNo stock prices for these years
  4. NeoGenomics, Inc.Public company
    • Director? – PresentNo stock prices for these years
  5. Prime Medicine, Inc.Public company
    • Director? – PresentNo stock prices for these years
  6. Aprea Therapeutics, Inc.Public company
    • Director? – PresentNo stock prices for these years
  7. HOOKIPA Pharma, Inc.Public company · 2 yr
    • Director2020 – 2022 · 2 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?